Aviance Capital Partners, LLC Laboratory Corp Of America Holdings Transaction History

Aviance Capital Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	BUY	$209.01 - $232.56 $56,850 - $63,256	272 Added 7.69%	3,808 $831,000
Q4 2023 Feb 06, 2024	BUY	$197.69 - $227.29 $1,186 - $1,363	6 Added 0.17%	3,536 $803,000
Q3 2023 Nov 06, 2023	SELL	$201.05 - $221.7 $22,316 - $24,608	-111 Reduced 3.05%	3,530 $709,000
Q2 2023 Aug 04, 2023	BUY	$211.93 - $241.33 $158,311 - $180,273	747 Added 25.81%	3,641 $878,000
Q1 2023 May 10, 2023	BUY	$213.32 - $257.83 $10,452 - $12,633	49 Added 1.72%	2,894 $663,000
Q4 2022 Feb 06, 2023	BUY	$203.72 - $248.97 $579,583 - $708,319	2,845 New	2,845 $669,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Aviance Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Aviance Capital Partners, LLC with notifications on news.